Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (6), 821-825
- https://doi.org/10.1016/s0959-8049(05)80417-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of oral clodronate on bone painInternational Urology and Nephrology, 1992
- Hormone-Resistant Metastatic Prostate CancerEuropean Urology, 1991
- Some Limitations of the Radioisotope Bone Scan in Patients With Metastatic Prostatic CancerCancer, 1990
- Clodronate Therapy of Metastatic Bone Disease in Patients with Prostatic CarcinomaPublished by Springer Nature ,1989
- Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scanCancer, 1988
- Carcinoma of the prostate. Hormonal therapyCancer, 1987
- Dichloromethylene-Diphosphonate in Patients with Prostatic Carcinoma Metastatic to the SkeletonJournal of Urology, 1985
- Hormonal Therapy of Prostatic CancerCancer, 1980
- Prostatic CarcinomaNew England Journal of Medicine, 1979
- Chemotherapy of advanced prostatic cancer Evaluation of response parametersUrology, 1976